Shim Clinic Logo
HIV PEP:
Stop HIV within 72 hours of sex
HIV Testing:
20 min result, 28 days after sex
STD Testing:
Full & comprehensive

Hepatitis B, Singapore - Shim Clinic

Hepatitis B Singapore: Hepatitis B is an infection of the liver caused by the Hepatitis B virus.

Hepatitis B infection is caused by the Hepatitis B virus and is usually screened for by detecting HBsAg in the blood. Immunity may be discerned by detecting HBsAb, and if absent, the Hepatitis B vaccine or Twinrix® vaccine may be given.

  • The hepatitis B virus is 100 times more infectious than HIV, the virus that causes AIDS, and infects about 10 times more people than HIV worldwide.
  • Hepatitis B virus infects the liver, and more than 350 million people in the world are lifelong hepatitis B virus carriers.
  • Long-term hepatitis B virus infection causes at least one million premature deaths every year from cirrhosis of the liver or liver cancer. It is second only to tobacco as the leading cause of cancer in humans.
  • Among the Hepatitis B carriers, 25% will develop serious liver diseases, including chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
  • The hepatitis B virus can be passed from an infected mother to her baby during childbirth, 1 in 20 Singaporeans are chronically infected with hepatitis B virus.


Blog articles about #hepatitisB


Latest News

Aspirin may reduce risk for liver cancer in hepatitis B patients, study says
Sat, 21 Oct 2017 06:23:07 +0800 | Health News - UPI.com
Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests. (Source: Health News - UPI.com)

Medical News Today: Daily aspirin could ward off liver cancer
Fri, 20 Oct 2017 23:00:00 +0800 | Health News from Medical News Today
Taking aspirin every day could help to lower the risk of liver cancer for patients infected with hepatitis B, a new study suggests. (Source: Health News from Medical News Today)

Can Aspirin Stop Liver Cancer in Hepatitis B Patients?
Fri, 20 Oct 2017 16:00:24 +0800 | Drugs.com - Daily MedNews
FRIDAY, Oct. 20, 2017 -- Daily aspirin may reduce the risk of liver cancer for people with hepatitis B infection, a new study suggests. Hepatitis B virus attacks the liver and can cause cirrhosis and liver cancer. Previous research suggests daily... (Source: Drugs.com - Daily MedNews)

Bucks biopharm firm signs licensing deal with California onco-immunology company
Wed, 18 Oct 2017 23:39:52 +0800 | bizjournals.com Health Care:Pharmaceuticals headlines
Arbutus BioPharma Corp., a Bucks County company developing treatments to cure hepatitis B infections, has entered into a collaboration and licensing deal with a California biopharmaceutical company developing personalized cancer immunotherapies. Under the terms of this license agreement, Gritstone Oncology of Emeryville, Calif., gets worldwide access to Arbutus’ portfolio of proprietary and clinically validated lipid nanoparticle [LNP] products and associated intellectual property. Gritstone will… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Alnylam to partner with Scangos-led biotech on infectious disease drugs
Wed, 18 Oct 2017 22:15:56 +0800 | bizjournals.com Health Care:Pharmaceuticals headlines
Vir Biotechnology, a San Francisco-based startup led by former Biogen CEO George Scangos, said Wednesday that it will work with Alnylam Pharmaceuticals to develop infectious disease treatments using the Cambridge company ’s experimental technology. Under the agreement, the companies will collaborate to develop one of Alnylam’s (Nasdaq: ALNY) potential drugs for hepatitis B, plus up to four additional treatments for infectious diseases. Alnylam will be eligible to receive over $1 billion in payments… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)

Alnyalm, Vir partner on RNAi-based hep B treatment
Wed, 18 Oct 2017 20:56:27 +0800 | Reuters: Health
(Reuters) - Drug developer Alnylam Pharmaceuticals Inc said on Wednesday it would scrap its hepatitis B (HBV) drug development and instead work with Vir Biotechnology on a new treatment for the disease. (Source: Reuters: Health)

Alnyalm, Vir partner on RNAi-based drugs for infectious diseases
Wed, 18 Oct 2017 19:46:48 +0800 | Reuters: Health
(Reuters) - Drug developer Alnylam Pharmaceuticals Inc entered into an agreement with privately held Vir Biotechnology on Wednesday to develop a new class of RNAi-based treatments for infectious diseases, including chronic hepatitis B. (Source: Reuters: Health)

Another Outbreak Related to the Nation ’s Opioid Crisis: Hepatitis C
Tue, 17 Oct 2017 12:00:00 +0800 | News stories via the Rural Assistance Center
Details the increased rates of Hepatitis C and how they correlate to the opioid epidemic by looking at West Virginia, which has the highest rates of overdose deaths and new hepatitis B and C infections in the country. Because those infected with hepatitis often do not display symptoms immediately, the disease can go untreated for years, leading eventually to end-stage liver disease. This is one among many diseases that are rising in the midst of the opioid epidemic, and although there is a treatment for it, for many it is not affordable. (May require subscription to view full article.) (Source: News stories via the Rural Assistance Center)

Progress in Fatty Liver and Pediatric Liver Disease Progress in Fatty Liver and Pediatric Liver Disease
Thu, 12 Oct 2017 03:34:17 +0800 | Medscape Medical News Headlines
New findings on nonalcoholic steatohepatitis, pediatric liver diseases, hepatitis B, and the microbiome will be among the topics tackled at the upcoming Liver Meeting.Medscape Medical News (Source: Medscape Medical News Headlines)

Ethiopia: Sustaining HBV Intervention Success Stories
Wed, 11 Oct 2017 21:41:51 +0800 | AllAfrica News: Health and Medicine
[Ethiopian Herald] Viral hepatitis result in a potentially life-threatening inflammation of the liver, which is characterized by complications of liver disease. Specifically, hepatitis B (HBV) and C (HCV) viruses alone cause chronic viral hepatitis which is a major global health problem responsible for 57_per cent of liver cirrhosis and 75_per cent of primary liver cancer cases, respectively. (Source: AllAfrica News: Health and Medicine)


Related Concepts

Vaccine

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis)
– Stop HIV infection before exposure
STD vaccine:
Hepatitis vaccine
HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV PEP (post-exposure prophylaxis)
– Stop HIV infection after exposure
STD testing *
Screening test
– to look for asymptomatic infections
– from previous exposures
Emergency contraception
with the
morning-after pill
(females only)
2 weeks HIV DNA Test
1 month HIV 4th Generation Test
SD Bioline HIV Ag/Ab Combo
– Fingerprick blood sampling.
20 minutes to results
3 months HIV 3rd Generation Test
OraQuick® HIV-1/2 Antibody
– Oral fluid or
– Fingerprick blood sampling.
20 minutes to results
STD testing *
– Full & comprehensive
diagnostic test
– to look for current infections
Watch for HIV Symptoms STD Symptoms
If infected HIV Treatment STD Treatment Abortion

* Males: Do not urinate for at least 4 hours before arriving.
* Females: testing is more accurate when you are not menstruating.


Private & Confidential Service